Section 5 of 5
Conclusion
Liya Anto, Lidan Gao, Jaeeun Lee, Chelsea Garcia, Oliver Otoko, Emma Hickey, Neha Mishra, Siyun Kim, Sung Gi Noh, Mi-Bo Kim, Hyunju Kang, Saki Mihori, Saurav Ranjitkar, Alison B. Kohan, Young-Ki Park, Anthony A. Provatas, Clinton Mathias, Oh Sung Kwon, Robert B. Clark, Ji-Young Lee, Frank C. Nichols, and Christopher N. Blesso · about 1 minutes
Overall, this work identifies microbiome-derived GLs as a novel class of bioactive molecules that may mediate the hepatoprotective effects of commensal microbes against metabolic liver disease. The ability to modulate these protective molecules through dietary fiber intake offers significant clinical potential for preventing and treating MASLD, particularly given the growing global burden of metabolic liver disease.